Bill Gross warns on gold momentum as regional bank stocks tumble
DUBLIN - BlackRock, Inc. has disclosed a 1.61% stake in Mural Oncology plc, according to a regulatory filing published Tuesday.
The investment management firm reported ownership of 279,760 shares in the oncology company, based on an Irish Takeover Panel opening position disclosure. The position includes 279,745 shares owned or controlled and 15 shares through cash-settled derivatives.
The disclosure, made under Rule 8.3 of the Irish Takeover Panel Act, is required when an entity holds interests in relevant securities representing 1% or more of a company that may be involved in a takeover situation.
BlackRock’s filing shows the position was held as of September 8, 2025, and includes details of a stock loan transaction involving 800 ordinary shares.
The disclosure indicates BlackRock holds no short positions in Mural Oncology securities.
The filing was submitted as a Form 8.3, which is typically used for disclosures related to companies involved in potential takeover situations, though no specific offer details were included in the statement.
The information was provided through a Regulatory Information Service filing based on the London Stock Exchange news service requirements.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.